Literature DB >> 6767453

Complement, opsonins, and the immune response to bacterial infection in burned patients.

A B Bjornson, W A Altemeier, H S Bjornson.   

Abstract

Studies were performed to evaluate complement, opsonins, and the immune response to bacterial infection in burned patients. Concentrations and functional acitivities of components of the classical and alternative complement pathways were measured in the sera of four septic, two bacteremic, and four nonseptic burned patients. In addition, heat-labile and heat-stable opsonic activity and agglutinin titers directed against the infecting bacterial strains were measured in the sera of the four septic patients and in an additional group of 11 septic burned patients with abnormal complement profiles. Functional activity of the alternative complement pathway and the concentration of properdin were shown to be persistently decreased during eight weeks postburn in the septic, bacteremic, and nonseptic burned patients; reduced classical pathway activity was demonstrated during the initial postburn period only in the septic patients. Two of the 15 septic patients had decreased heat-labile serum opsonic activity for their infecting bacterial strains, which occurred only during the initial postburn period. Heat-stable opsonins and agglutinin titers in the patients' sera directed against the infecting bacterial strains were equivalent to those in normal human sera, except for the agglutinin titers to Streptococcus faecalis which were increased in the patients' sera in comparison to the normal sera. These results indicate that the multiple complement abnormalities which occur in septic burned patients do not predispose these patients to bacterial infection by decreasing serum opsonic activity. Moreover, heat-stable immune IgG antibodies are not produced during septicemia which facilitate opsonization of the infecting bacterial strains in the absence of an intact complement system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767453      PMCID: PMC1344703          DOI: 10.1097/00000658-198003000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Antigenic determinants of human beta-1c and beta-1g-globulins.

Authors:  C West; N C Davis; J Forristal; J Herbst; R Spitzer
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

2.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

3.  Abnormal immune response in burns.

Authors:  J Kohn
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Prevention of invasive pseudomonas infection in burns with a new vaccine.

Authors:  J W Alexander; M W Fisher; B G MacMillan; W A Altemeier
Journal:  Arch Surg       Date:  1969-08

6.  Active immunoprophylaxis in burns with a new multivalent vaccine.

Authors:  A Sachs
Journal:  Lancet       Date:  1970-11-07       Impact factor: 79.321

7.  Antibody production in mice after thermal and tourniquet trauma.

Authors:  K Markley; E Smallman; G Evans
Journal:  Surgery       Date:  1967-06       Impact factor: 3.982

8.  Alterations of the immune response following severe thermal injury.

Authors:  J W Alexander; J A Moncrief
Journal:  Arch Surg       Date:  1966-07

9.  Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.

Authors:  E J Ruley; J Forristal; N C Davis; C Andres; C D West
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

10.  Fourth component of human complement: description of a three polypeptide chain structure.

Authors:  R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  9 in total

1.  Polymorphonuclear leukocyte function and serum opsonic activity in surgical patients.

Authors:  T Inoue; M Obata; Y Mishima
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  A systematic study of host defense processes in badly injured patients.

Authors:  H C Polk; C D George; S R Wellhausen; K Cost; P R Davidson; M P Regan; A P Borzotta
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

3.  Complement activation and neutrophil dysfunction in burned patients with sepsis--a study of two cases.

Authors:  J Utoh; T Utsunomiya; T Imamura; H Katsuya; Y Miyauchi; T Kambara
Journal:  Jpn J Surg       Date:  1989-07

4.  Depressed immune response in burn patients: use of monoclonal antibodies and functional assays to define the role of suppressor cells.

Authors:  A J McIrvine; J B O'Mahony; I Saporoschetz; J A Mannick
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

5.  Reduction in alternative complement pathway mediated C3 conversion following burn injury.

Authors:  A B Bjornson; H S Bjornson; W A Altemeier
Journal:  Ann Surg       Date:  1981-08       Impact factor: 12.969

6.  Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis.

Authors:  M E Lanser; T M Saba; W A Scovill
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

7.  Serum-mediated inhibition of polymorphonuclear leukocyte function following burn injury.

Authors:  A B Bjornson; H S Bjornson; W A Altemeier
Journal:  Ann Surg       Date:  1981-11       Impact factor: 12.969

8.  Depressed natural killer cell function in thermally injured adults: successful in vivo and in vitro immunomodulation and the role of endotoxin.

Authors:  B S Bender; R A Winchurch; J N Thupari; J J Proust; W H Adler; A M Munster
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

9.  The capacity of serum to support neutrophil phagocytosis is a vital host defense mechanism in severely injured patients.

Authors:  H C Polk; C D George; M J Hershman; S R Wellhausen; W G Cheadle
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.